The burgeoning interest in incorporating psychedelics into therapeutic practices has seen a marked rise over the past few years. Recent...
FDA has approved two clinical trials studying the effects of PEX010, Filament's botanical psilocybin drug candidate. The post Filament Health Announces...
The FDA gave the nod to the University of Washington and UCLA. The post FDA Greenlights University Research of Filament Psychedelic Drug appeared first...
Algernon NeuroScience has completed a feasibility study and has finalized its clinical trial design for a 40 patient Phase 2 DMT Stroke study. The post...
Can the modern psychedelic medicine movement learn from traditional healing practices? The post The Intersection of Psychedelic Medicine and Traditional...
Want to grow your own mushrooms? Our guide has everything you need to know about mushroom grow kits from supplies needed to costs.
The release of quarterly financial reports over the past few weeks is providing some much-needed insight into the state of the industry. It is becoming...
Discover the psychedelic wonders of Hillbilly mushrooms in our detailed guide. Learn about their potency and dosage and how to identify them in the wi...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed The post News...
Source: Clive Maund 08/04/2023 Technical Analyst Clive Maund reviews Awakn Life Sciences Corp.'s 26-month and year-to-date charts to tell you...
Aspergillus fumigatus strains that infect humans have a significantly altered metabolism compared to other strains in the environment. At the same time,...
We take a look at how music can not only enhance the psychedelic experience but lead to better and more profound therapeutic outcomes. The post Exploring...
Welcome to Startups Weekly. Sign up here to get it in your inbox every Friday morning. State-sponsored bad actors have long been able to make “deepfake”...
Psychedelic science is in its infancy stage, so there is a lot that is still unknown. One of these unknowns is the safety and efficacy of...
MindMed released its Q3 financial results. Highlights include enrolment in Phase 2b LSD trial, top-line results by end-of-year, and $116 million in cash. The...
Cybin Inc. (NYSE American:CYBN / NEO:CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new...